Current CDC surveillance data show no active outbreaks meeting the agency's strict Level 4 criteria of extreme risk with no available precautions, supporting traders' 76% implied probability against issuance by December 31, 2026. Recent Ebola Bundibugyo outbreaks in the Democratic Republic of the Congo and Uganda prompted CDC Level 3 and Level 2 notices respectively, alongside enhanced U.S. entry screening, but case trajectories and official WHO assessments indicate contained transmission without the high-fatality, uncontainable spread historically required for Level 4 designation. Routine monitoring of influenza, mpox, and other pathogens shows moderate patterns consistent with historical baselines, with no model consensus projecting escalation before year-end. New situational reports and surveillance updates could alter this assessment if novel high-risk variants emerge.